Zenith Spiral-Z G55221Recalls & reported problems
Cook Incorporated · Zenith, Spiral-Z AAA Iliac Leg · Class 3 · Implant
All models of Zenith Spiral-Z (29)
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 5
- Deaths reported
- 0
- Injuries reported
- 4
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 5 adverse event reports that list this exact device (DI 10827002552217), received between Apr 7, 2016 and Jun 25, 2024 — classified as 4 injuries, 1 malfunction.
The most frequently reported specific device problem is “Obstruction of Flow” (4 reports).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Reports received per month
Most reported problems
Device problems
- Obstruction of Flow4
- Inadequacy of Device Shape and/or Size1
Patient problems
- Thrombosis/Thrombus2
- Insufficient Information1
- Myocardial Infarction1
- No Code Available1
- No Known Impact Or Consequence To Patient1
- Obstruction/Occlusion1
Recent adverse event reports
The 5 most recent of 5 reports, in the reporter's own words as published by the FDA.
InjuryJun 25, 2024Obstruction of Flow; Obstruction of Flow
NO ADDITIONAL INFORMATION REGARDING PATIENT AND/OR EVENT DETAILS HAS BEEN RECEIVED SINCE THE PREVIOUS MEDWATCH REPORT WAS SENT.
Patient problems: Thrombosis/Thrombus
MAUDE report 19605541 ↗InjuryApr 13, 2023Obstruction of Flow; Obstruction of Flow
NO ADDITIONAL INFORMATION REGARDING THE PATIENT AND/OR EVENT HAS BEEN RECEIVED SINCE THE PREVIOUS MEDWATCH REPORT WAS SENT.
Patient problems: Obstruction/Occlusion
MAUDE report 16736955 ↗InjuryFeb 15, 2022Obstruction of Flow; Obstruction of Flow
IT WAS REPORTED THAT THERE WAS OCCLUSION OF THE RIGHT ILIAC ZENITH LEG GRAFT PLACED IN THE RIGHT EXTERNAL ILIAC ARTERY. THIS REPORT IS RELATED TO ANOTHER MDR WITH PATIENT IDENTIFIER: (B)(6). THE PATIENT WAS ENROLLED IN STUDY 14-09. AT THE TIME OF ENROLLMENT, PRE-PROCEDURE IMAGING CONDUCTED BY THE SITE NOTED A STABLE JUXTA RENAL AORTIC ANEURYSM. THE PROXIMAL SEALING ZONE SHOWED NO CALCIFICATION, OCCLUSIVE DISEASE, OR THROMBUS. THERE WAS NO CALCIFICATION, OCCLUSIVE DISEASE OF THE BILATERAL COMMON AND EXTERNAL ILIAC ARTERIES. THERE WAS NO TORTUOSITY OF THE BILATERAL ILIAC ARTERIES. INDEPENDENT LAB ANALYSIS NOTED AN ANEURYSM DIAMETER OF 58.3 MM. THE PROXIMAL SEALING ZONE WAS PARALLEL SHAPED AND SHOWED NO CALCIFICATION, OCCLUSIVE DISEASE, OR THROMBUS. THE INDEPENDENT LAB ALSO CONFIRMED THAT THERE WAS NO CALCIFICATION OR OCCLUSIVE DISEASE OF THE BILATERAL COMMON ILIAC ARTERIES. THE INDEPENDENT LAB STATED THERE WAS MILD TORTUOSITY OF THE BILATERAL ILIAC ARTERIES. THERE WAS NO CALCIFICATION OR OCCLUSIVE DISEASE OF THE RIGHT EXTERNAL ILIAC ARTERY. THERE WAS MILD CALCIFICATION BUT NO OCCLUSIVE DISEASE OF THE LEFT EXTERNAL ILIAC ARTERY. ON (B)(6) 2018, THE PATIENT UNDERWENT AN ENDOVASCULAR AO
Patient problems: Insufficient Information; Myocardial Infarction; Thrombosis/Thrombus
MAUDE report 13538750 ↗InjuryDec 14, 2018Obstruction of Flow; Obstruction of Flow
NO NEW EVENT DESCRIPTION INFORMATION TO REPORT AT THIS TIME.
Patient problems: No Code Available
MAUDE report 8166866 ↗MalfunctionApr 7, 2016Inadequacy of Device Shape and/or Size; Inadequacy of Device Shape and/or Size
DURING A PROCEDURE ON A (B)(6) MALE PATIENT, THE MAINBODY WAS PLACED INITIALLY. THEN THE 9 MM X 90 MM ENDOVASCULAR ILIAC LEG GRAFT WAS PLACED BUT IT WAS TOO SHORT. AFTER THE PROCEDURE, THE PHYSICIAN MEASURED THE LEG GRAFT VIA X-RAY AND THE GRAFT MEASURED A 9 MM X 74 MM LONG LEG INSTEAD. A SECTION OF THE DEVICE DID NOT REMAIN INSIDE THE PATIENT'S BODY. ACCORDING TO THE INITIAL REPORTER, THE PATIENT DID NOT REQUIRE ANY ADDITIONAL PROCEDURES NOR EXPERIENCE ANY ADVERSE EFFECTS DUE TO THIS OCCURRENCE. THE IMPLANTED LEG GRAFT IS SHORT, BUT THE PATIENT IS REPORTED TO BE DOING FINE.
Patient problems: No Known Impact Or Consequence To Patient
MAUDE report 5553748 ↗
Other SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT devices
- Endurant® IIs ESBF2814C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls34 deaths254 reports
- Endurant® IIs ESBF3214C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls19 deaths173 reports
- Endurant® IIs ESBF3614C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT1 recall37 deaths214 reports
- Endurant® IIs ESBF2514C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls18 deaths136 reports
- Endurant® IIs ESBF2314C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls9 deaths60 reports
- RelayPro Thoracic Stent-Graft System 28-N4-34-154-34UBolton Medical Inc. · System, Endovascular Graft, Aortic Aneurysm Treatment3 recalls7 reports
- Vela Proximal Endograft System A34-34/C100-O20 VEndologix LLC · System, Endovascular Graft, Aortic Aneurysm Treatment3 deaths152 reports
- Endurant® II ETCF2828C49EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls7 deaths44 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page